Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/44316
Type
PreprintCopyright
Open access
Collections
- IFF - Preprint [14]
- MS - Preprint [4]
Metadata
Show full item record50
CITATIONS
50
Total citations
1
Recent citation
14
Field Citation Ratio
2.63
Relative Citation Ratio
REINFECTION OF COVID-19 AFTER 3 MONTHS WITH A DISTINCT AND MORE AGGRESSIVE CLINICAL PRESENTATION: CASE REPORT
Immune responses
Immunity
Immunization
Virus classification
SARS coronavirus
Immune responses
Reinfection
Social Science
Public policy
Immune responses
Inflammation
Epidemiology
COVID-19
Author
Affilliation
Hospital Federal da Lagoa. Rio de Janeiro, RJ, Brasil.
Universidade do Rio de Janeiro. Hospital Universitário Gaffrée-Guinle. Rio de Janeiro, RJ, Brasil.
Grupo Fleury. São Paulo, SP, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Rio de Janeiro, RJ, Brasil,
Instituto Nacional do Câncer. Rio de Janeiro, RJ, Brasil,
Fundação Oswaldo Cruz. Fiocruz Mato Grosso do Sul. Campo Grande, MS, Brasil,
Universidade do Rio de Janeiro. Hospital Universitário Gaffrée-Guinle. Rio de Janeiro, RJ, Brasil.
Grupo Fleury. São Paulo, SP, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Rio de Janeiro, RJ, Brasil,
Instituto Nacional do Câncer. Rio de Janeiro, RJ, Brasil,
Fundação Oswaldo Cruz. Fiocruz Mato Grosso do Sul. Campo Grande, MS, Brasil,
Abstract
The sudden pandemic caused by SARS-CoV-2 exposed healthcare professionals worldwide to high viral loads, in an early epidemiological moment, often without the recommended personal protective equipment. We report the case of a Brazilian doctor who, after presenting a mild clinical episode of COVID-19 with molecular confirmation by RT-PCR in March 2020, appeared with a new acute infection by SARS-CoV-2 three months later. In middle of June, she had significant and very specific symptoms of COVID-19 with tomographic and serological confirmation of reinfection. There is a strong probability that these two episodes of infection were caused by different viral strains and that each genetic variation is related to specific clinical manifestations. We observed that, in addition to the different symptoms presented in the reinfections' episode, there was a more intense organic inflammatory response to the virus, with clinical repercussion. This clinical case should be an alert regarding the maintenance of individual protection among health cares, even in individuals who have already had COVID-19, since there is still no guarantee of prolonged immunity. This article is protected by copyright. All rights reserved.
Keywords
Humoral immunityImmune responses
Immunity
Immunization
Virus classification
SARS coronavirus
Immune responses
Reinfection
Social Science
Public policy
Immune responses
Inflammation
Epidemiology
COVID-19
Share